The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera.

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Medicine

Pathology

Genetics

Show all topics

DOI

10.1101/2020.08.21.261727

License

cc-no